Aminophylline is a drug combination that contains theophylline and ethylenediamine in a 2:1 ratio. Once in the body, theophylline is released and acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Similar to other theophyllines, aminophylline is indicated for the treatment of lung diseases such as asthma, chronic bronchitis, and COPD. The majority of aminophylline medications are discontinued and the remaining medications on the market are in short supply.
For the treatment of bronchospasm due to asthma, emphysema and chronic bronchitis.
Siriraj hospital, Mahidol university, Bangkok, Thailand
Treviso Regional Hospital, Treviso, TV, Italy
ULSS2 Marca Trevigiana, Treviso, Italy
ULSS 2 Marca Trevigiana, Treviso, Tv, Italy
University of Malaya, Kuala Lumpur, Malaysia
Tanta University Hospitals, Tanta, ElGharbiaa, Egypt
Tanta University Hospitals, Tanta, ElGharbiaa, Egypt
Kasr Alainy, Cairo, Egypt
faculty of medicine, Ain Shams University, Cairo, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.